Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis C

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    November 2022
  1. CHUMBE A, Urbanowicz RA, Sliepen K, Koekkoek SM, et al
    Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    October 2022
  2. STRANG BL
    Toward inhibition of human cytomegalovirus replication with compounds targeting cellular proteins.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    August 2022
  3. NEUFELDT CJ, Cortese M
    Membrane architects: how positive-strand RNA viruses restructure the cell.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    April 2022
  4. BAMFORD CGG, McLauchlan J
    Corrigendum: An interferon lambda 4-associated variant in the hepatitis C virus RNA polymerase affects viral replication in infected cells.
    J Gen Virol. 2022;103.
    PubMed    


    March 2022
  5. ELSHEIKH MEA, McClure CP, Tarr AW, Irving WL, et al
    Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    February 2022
  6. SONI S, Singh D, Aggarwal R, Veerapu NS, et al
    Enhanced fitness of hepatitis C virus increases resistance to direct-acting antivirals.
    J Gen Virol. 2022;103.
    PubMed     Abstract available


    December 2021
  7. LEE S, Yoon H, Han J, Jang KL, et al
    Hepatitis C virus core protein inhibits hepatitis B virus replication by downregulating HBx levels via Siah-1-mediated proteasomal degradation during coinfection.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


  8. CHEN M, Xu Y, Li N, Yin P, et al
    Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    May 2021
  9. THE MICROBIOLOGY SOCIETY
    Retraction notice: Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes.
    J Gen Virol. 2021;102.
    PubMed    


    March 2021
  10. BREITINGER U, Farag NS, Ali NKM, Ahmed M, et al
    Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    J Gen Virol. 2021 Mar 12. doi: 10.1099/jgv.0.001571.
    PubMed     Abstract available


  11. FERNANDES CAMPOS GR, Ward J, Chen S, Bittar C, et al
    Corrigendum: A novel substitution in NS5A enhances resistance of hepatitis C virus genotype 3 to daclatasvir.
    J Gen Virol. 2021;102.
    PubMed    


  12. SIMMONDS P, Williams S, Harvala H
    Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    J Gen Virol. 2021;102.
    PubMed     Abstract available


    November 2020
  13. KALEMERA MD, Capella-Pujol J, Chumbe A, Underwood A, et al
    Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins.
    J Gen Virol. 2020 Nov 4. doi: 10.1099/jgv.0.001512.
    PubMed     Abstract available


  14. FERNANDES CAMPOS GR, Ward J, Chen S, Bittar C, et al
    A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir.
    J Gen Virol. 2020 Nov 3. doi: 10.1099/jgv.0.001496.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: